阿替普酶联合丁苯酞对脑梗死的疗效和炎性因子的影响
[Abstract]:To investigate the effect of atropase combined with butyphthalide on the treatment of acute cerebral infarction and its effect on serum MMP-9 and VEGF levels. 80 patients with acute cerebral infarction admitted from October 2014 to December 2015 were randomly divided into two groups: 40 patients in combination group and 40 patients in atropase group. The patients in the combined group were treated with atropase, and the patients in the combined group were treated with butyphthalide on the basis of atropase group. The course of treatment was 14 days, and the improvement of nerve function was compared between the combined group and the atropase group. Changes in inflammatory factor levels and the clinical efficacy of the patients. The concentration of MMP-9 and VEGF were detected by Elisa. There was no significant difference in NIHSS score and Barthel index score between the combined group and atropase group before treatment (p0.05). The NIHSS scores in the combined group were significantly lower than those before the treatment (p0.05), and the Barthel index score in the combined group was higher than that before the treatment (p0.05). On the 7th and 14th days after treatment, there were significant differences in NIHSS score and BI index between the combined group and the atropase group (p0.05). The total effective rate of the Atipase group was 80%, which was lower than that of the combined group (95%). There was no statistical difference in serum MMP-9VEGF content between the two groups before treatment. Clinical significance (p0.05), 7 and 14 days after treatment, The level of MMP-9 in serum of the combined group was significantly lower than that of the atropase group (p0.05). The level of VEGF in the combined group was significantly higher than that in the atropase group (p0.05). After the treatment of acute cerebral infarction with Atidase combined with butyphthalide, the level of MMP-9 inflammatory factor was significantly decreased, the concentration of vascular endothelial cytokine was increased, the function of brain cells was protected and the nerve function was improved.
【作者单位】: 三峡大学神经病学研究所;宜昌市中心人民医院;
【分类号】:R743.33
【相似文献】
中国期刊全文数据库 前10条
1 颜滢;黄晨;姚科;;注射用阿替普酶致颅内出血1例[J];中国药物警戒;2010年11期
2 海燕;;名刊[J];中国处方药;2008年10期
3 陈学东;王中华;田磊;杨晓冬;王世华;王育红;;阿替普酶治疗下肢深静脉血栓形成的临床研究[J];中国普通外科杂志;2011年12期
4 张世江;;小剂量阿替普酶治疗老老年急性心肌梗死的疗效[J];实用药物与临床;2011年06期
5 杜菲;;阿替普酶直接给药以溶解腿部血栓[J];心血管病防治知识(科普版);2012年03期
6 金秉祥;;急性缺血性脑卒中阿替普酶溶栓预后影响因素临床研究[J];中国卫生产业;2013年26期
7 阙俐,吴伟;可与阿替普酶媲美的新型血栓溶解药[J];国外医药(合成药 生化药 制剂分册);2000年04期
8 邓晓丽;张艺;;10例肺栓塞病人应用阿替普酶溶栓治疗的护理[J];全科护理;2013年28期
9 高志红;宁鸿珍;;阿替普酶静脉溶栓治疗急性脑梗死效果观察及护理对策[J];临床合理用药杂志;2014年04期
10 宁俊凯;杨昌云;;阿替普酶致畏冷寒战高热1例[J];医药导报;2014年08期
中国重要会议论文全文数据库 前4条
1 林芳芳;;阿替普酶治疗1例急性脑梗死患者的护理体会[A];2012年河南省急诊新业务、新视角、新理念及规范化管理研讨会论文集[C];2012年
2 黄瑾;周博;鲁静;;阿替普酶治疗下肢深静脉血栓的护理体会[A];中华护理学会第8届全国造口、伤口、失禁护理学术交流会议、全国外科护理学术交流会议、全国神经内、外科护理学术交流会议论文汇编[C];2011年
3 黄瑾;周博;鲁静;;阿替普酶治疗糖尿病患者下肢深静脉血栓的护理体会[A];全国内科护理学术交流会议、全国心脏内、外科护理学术交流会议、第9届全国糖尿病护理学术交流会议、第9届全国血液净化护理学术交流会议论文汇编[C];2011年
4 朱碧宏;王志敏;黄丹江;韩钊;;阿替普酶在脑梗死4.5小时内静脉溶栓回顾性分析[A];2012年浙江省神经病学学术年会论文集[C];2012年
中国重要报纸全文数据库 前1条
1 徐蜀远;溶栓药物的研究进展(下)[N];中国医药报;2001年
中国博士学位论文全文数据库 前2条
1 朱子龙;芬戈莫德联合阿替普酶治疗急性缺血性脑卒中探究性研究[D];天津医科大学;2016年
2 林念童;急性缺血性脑卒中阿替普酶溶栓预后影响因素临床研究[D];南方医科大学;2012年
中国硕士学位论文全文数据库 前6条
1 梁晶;阿替普酶与巴曲酶治疗急性脑梗死的疗效及安全性比较研究[D];吉林大学;2015年
2 陈川;阿替普酶与尿激酶静脉溶栓治疗急性缺血性脑卒中疗效和安全性的Meta分析[D];广西医科大学;2016年
3 彭博;尿激酶及阿替普酶治疗急性脑梗死疗效及安全性的比较研究[D];大连医科大学;2014年
4 刘备;阿替普酶辅助微创术治疗脑出血的临床观察[D];重庆医科大学;2014年
5 崔悦;阿替普酶治疗急性脑梗死的疗效观察[D];天津医科大学;2014年
6 林艳;阿替普酶对急性脑梗死大鼠超时间窗静脉溶栓的疗效评价[D];山东大学;2014年
,本文编号:2132547
本文链接:https://www.wllwen.com/yixuelunwen/shenjingyixue/2132547.html